Q4 2019
Released Feb 13, 2020, after the close
10-K filed Feb 13, 2020, 44 days after period end · 0001564590-20-004605
Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$1.98M-$1.98M derivedN/M vs Q4 2018N/M vs Q3 2019
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$2,224,132N/M
Operating Cash Flowderived-$2,404,382N/M
Free Cash Flowderived-$2,411,641N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2019dderived from reported figures | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Net Income | -$1.98M | -$208.00K | -$1.60M | -$1.45K |
| EPS Diluted | — | $0.00 | -$0.02 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR